Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
Recurrences of Hodgkin's Lymphoma (HL) 5 years after the initial therapy are rare. The aim of this study is to report a single centre experience of the clinical characteristics, outcome, and toxicity of pts who experienced very late relapses, defined as relapses that occurred 5 or more years af...
Saved in:
Main Authors: | Francesco Gaudio, Annamaria Giordano, Vincenzo Pavone, Tommasina Perrone, Paola Curci, Domenico Pastore, Mario Delia, Clara de' Risi, Alessandro Spina, Vincenzo Liso, Giorgina Specchia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2011/707542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients
by: Evgeny Klyuchnikov, et al.
Published: (2011-01-01) -
Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01) -
Epstein–Barr Virus Driven Hodgkin’s Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma
by: Moeen Mohammadi-Oroujeh, et al.
Published: (2023-01-01) -
NonHodgkin's Lymphoma with Peritoneal Localization
by: E. Curakova, et al.
Published: (2014-01-01) -
Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma
by: Rekha Chandran, et al.
Published: (2013-01-01)